Summary
GLAXOSMITHKLINE issued more encouraging updates on two fledgling drugs providing a much needed tonic for the shares (up 16p to Pounds 11.63).
It underlines analysts' claims that GSK has the strongest new- products pipeline of any pharmaceutical firm.See the full content of this document
Extract
Pulses Race Over Drugs in Glaxo Pipeline
Studies show its breast cancer pill Lap...
See the full content of this document
Sponsored links
